©2011 Baishideng Publishing Group Co.
World J Cardiol. Nov 26, 2011; 3(11): 367-373
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367
Table 3 Angiographic and procedural characteristics (n = 178) n (%)
| Lesion type classification | |
| A | 40 (23.1) |
| B | 103 (59.5) |
| C | 25 (17.4) |
| Chronic total occlusion | 9 (5.2) |
| Bifurcation | 30 (17.3) |
| Access site | |
| Transradial | 133 (74.8) |
| Transfemoral | 52 (25.2) |
| Direct stenting | 45 (25.3) |
| DES | 26 (14.6) |
| Length of implanted stents (mm, mean ± SD) | 22.3 ± 11.6 |
| Diameter of implanted stents (mm, mean ± SD) | 3.18 ± 1.24 |
| QCA analysis (mean ± SD) | |
| Reference diameter pre (mm) | 2.9 ± 0.67 |
| Reference diameter post (mm) | 3.0 ± 0.55 |
| MLD pre (mm) | 0.74 ± 0.5 |
| MLD post (mm) | 2.6 ± 0.5 |
| % stenosis pre | 74.6 ± 16.1 |
| % stenosis post | 12.3 ± 8.9 |
| Acute gain (mm) | 1.8 ± 0.6 |
- Citation: Brugaletta S, Martin-Yuste V, Ferreira-González I, Cola C, Alvarez-Contreras L, Antonio MD, Garcia-Moll X, García-Picart J, Martí V, Balcells-Iranzo J, Sabaté M. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(11): 367-373
- URL: https://www.wjgnet.com/1949-8462/full/v3/i11/367.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i11.367